Bruker Corporation Announces Acquisition of Canopy Biosciences, LLC
Canopy Biosciences is a leader in high multiplex biomarker imaging for immunology, immuno-oncology and cell therapy.
September 11, 2020
Medical Device News Magazine is the leading resource for medical device M&A information. We provide coverage of all the latest deals, as well as insights and analyses from industry experts.
Our readers rely on us for the most up-to-date information on the medical device market. We are focused on delivering the most comprehensive news coverage possible. Whether you are a CEO, CFO, investor, or employee of a medical device company, MDNM is the source you can trust for all your merger and acquisition news.
Canopy Biosciences is a leader in high multiplex biomarker imaging for immunology, immuno-oncology and cell therapy.
The acquired assets will be absorbed by Cambus Medical located in Galway, Ireland. Cambus Medical, a Freudenberg Medical company, is a market-leading hypotube manufacturer in the minimally invasive industry.